51 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34973473 | Pan-neuronal expression of human mutant huntingtin protein in Drosophila impairs immune response of hemocytes. | 2022 Feb 15 | 4 |
2 | 32941796 | Serine residues 13 and 16 are key modulators of mutant huntingtin induced toxicity in Drosophila. | 2021 Apr | 4 |
3 | 33772540 | Spinocerebellar Ataxia Type 1 protein Ataxin-1 is signaled to DNA damage by ataxia-telangiectasia mutated kinase. | 2021 May 17 | 1 |
4 | 34914364 | Polyglutamine-Specific Gold Nanoparticle Complex Alleviates Mutant Huntingtin-Induced Toxicity. | 2021 Dec 29 | 1 |
5 | 32967102 | Implications of the Orb2 Amyloid Structure in Huntington's Disease. | 2020 Sep 21 | 1 |
6 | 32975927 | Exploding the Repeat Length Paradigm while Exploring Amyloid Toxicity in Huntington's Disease. | 2020 Oct 20 | 1 |
7 | 30171891 | Mutational analysis implicates the amyloid fibril as the toxic entity in Huntington's disease. | 2018 Dec | 3 |
8 | 28235896 | Pathogenic Huntington Alters BMP Signaling and Synaptic Growth through Local Disruptions of Endosomal Compartments. | 2017 Mar 22 | 4 |
9 | 28871787 | NMR Spectroscopy-based Metabolomics of Drosophila Model of Huntington's Disease Suggests Altered Cell Energetics. | 2017 Oct 6 | 2 |
10 | 26728250 | Curcumin modulates cell death and is protective in Huntington's disease model. | 2016 Jan 5 | 6 |
11 | 26920069 | αB-Crystallin overexpression in astrocytes modulates the phenotype of the BACHD mouse model of Huntington's disease. | 2016 May 1 | 1 |
12 | 27309588 | Characterization of axonal transport defects in Drosophila Huntingtin mutants. | 2016 Sep - Dec | 4 |
13 | 27506601 | Altered lipid metabolism in Drosophila model of Huntington's disease. | 2016 Aug 10 | 4 |
14 | 25305076 | Comparative study of naturally occurring huntingtin fragments in Drosophila points to exon 1 as the most pathogenic species in Huntington's disease. | 2015 Feb 15 | 2 |
15 | 25761110 | Enhanced neuronal glucose transporter expression reveals metabolic choice in a HD Drosophila model. | 2015 | 1 |
16 | 25848931 | siRNA screen identifies QPCT as a druggable target for Huntington's disease. | 2015 May | 2 |
17 | 26942103 | Drosophila as a potential model to ameliorate mutant Huntington-mediated cardiac amyloidosis. | 2014 | 1 |
18 | 23555909 | Huntingtin's function in axonal transport is conserved in Drosophila melanogaster. | 2013 | 2 |
19 | 23652004 | A functional deficiency of TERA/VCP/p97 contributes to impaired DNA repair in multiple polyglutamine diseases. | 2013 | 1 |
20 | 23980182 | Huntington disease arises from a combinatory toxicity of polyglutamine and copper binding. | 2013 Sep 10 | 6 |
21 | 24022020 | Modeling Huntington disease in Drosophila: Insights into axonal transport defects and modifiers of toxicity. | 2013 Oct-Dec | 4 |
22 | 24367279 | Huntington's disease induced cardiac amyloidosis is reversed by modulating protein folding and oxidative stress pathways in the Drosophila heart. | 2013 | 5 |
23 | 21912091 | Pcaf modulates polyglutamine pathology in a Drosophila model of Huntington's disease. | 2012 | 1 |
24 | 22466800 | Rab11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington's disease. | 2012 Jul 1 | 2 |
25 | 22634544 | Drosophila eye color mutants as therapeutic tools for Huntington disease. | 2012 Apr-Jun | 2 |
26 | 22733771 | Axon injury and stress trigger a microtubule-based neuroprotective pathway. | 2012 Jul 17 | 2 |
27 | 22817726 | Choosing and using Drosophila models to characterize modifiers of Huntington's disease. | 2012 Aug | 4 |
28 | 21636279 | The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease. | 2011 Jun 7 | 2 |
29 | 21700213 | Neuronal store-operated calcium entry pathway as a novel therapeutic target for Huntington's disease treatment. | 2011 Jun 24 | 2 |
30 | 21909362 | High-content chemical and RNAi screens for suppressors of neurotoxicity in a Huntington's disease model. | 2011 | 1 |
31 | 22180703 | The biological function of the Huntingtin protein and its relevance to Huntington's Disease pathology. | 2011 Jan 1 | 1 |
32 | 20100940 | A genomewide RNA interference screen for modifiers of aggregates formation by mutant Huntingtin in Drosophila. | 2010 Apr | 3 |
33 | 20336775 | B2 attenuates polyglutamine-expanded androgen receptor toxicity in cell and fly models of spinal and bulbar muscular atrophy. | 2010 Aug 1 | 1 |
34 | 20399860 | Cystamine and intrabody co-treatment confers additional benefits in a fly model of Huntington's disease. | 2010 Oct | 2 |
35 | 20531388 | Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington's disease. | 2010 Jul 21 | 2 |
36 | 21087194 | Selection of behaviors and segmental coordination during larval locomotion is disrupted by nuclear polyglutamine inclusions in a new Drosophila Huntington's disease-like model. | 2010 Dec | 1 |
37 | 19268537 | Live axonal transport disruption by mutant huntingtin fragments in Drosophila motor neuron axons. | 2009 May | 2 |
38 | 19380309 | Inactivation of Drosophila Huntingtin affects long-term adult functioning and the pathogenesis of a Huntington's disease model. | 2009 May-Jun | 2 |
39 | 18065778 | AKT-sensitive or insensitive pathways of toxicity in glial cells and neurons in Drosophila models of Huntington's disease. | 2008 Mar 15 | 2 |
40 | 18417352 | Expression of expanded polyglutamine targets profilin for degradation and alters actin dynamics. | 2008 Jun | 1 |
41 | 18423405 | ROCK and PRK-2 mediate the inhibitory effect of Y-27632 on polyglutamine aggregation. | 2008 May 28 | 2 |
42 | 18430781 | Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. | 2008 May 15 | 2 |
43 | 17961788 | Interacting proteins as genetic modifiers of Huntington disease. | 2007 Nov | 1 |
44 | 16497721 | Rapamycin pre-treatment protects against apoptosis. | 2006 Apr 1 | 1 |
45 | 15590702 | Inactivation of Drosophila Apaf-1 related killer suppresses formation of polyglutamine aggregates and blocks polyglutamine pathogenesis. | 2005 Feb 1 | 1 |
46 | 15677486 | Expanded polyglutamine peptides disrupt EGF receptor signaling and glutamate transporter expression in Drosophila. | 2005 Mar 1 | 5 |
47 | 14978262 | Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. | 2004 Mar 2 | 1 |
48 | 15064418 | SUMO modification of Huntingtin and Huntington's disease pathology. | 2004 Apr 2 | 1 |
49 | 12379151 | The predominantly HEAT-like motif structure of huntingtin and its association and coincident nuclear entry with dorsal, an NF-kB/Rel/dorsal family transcription factor. | 2002 Oct 14 | 1 |
50 | 11607033 | Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila. | 2001 Oct 18 | 1 |